Nuzenio

Tradingview Dnli

Tradingview Dnli entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 8 latest news signals 1 publisher sources 100/100 entity strength

Latest news

DNLI Q2 Loss Narrows, Avlayah Sales Drive Strong Launch Momentum - TradingViewTradingView · Fri, 07 Aug 2026 18:31:00 GMTDenali Therapeutics Inc. Stock 12‑Month Price Target Raised to $35.44, Implies 43% Upside - TradingViewTradingView · Fri, 07 Aug 2026 14:20:14 GMTDNLI: AVLAYAH's launch drove $3.6M revenue and strong adoption, with Q3 guidance of $10–12M - TradingViewTradingView · Thu, 06 Aug 2026 23:10:45 GMTDenali Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:01:33 GMTDenali Therapeutics reports $3.6M in Q2 2026 product revenue, pro forma cash >$1.1B - TradingViewTradingView · Thu, 06 Aug 2026 20:13:22 GMTDenali Therapeutics Inc. 2026: Revenue $3.6M, EPS ($0.68) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMTDNLI: First AVLAYAH sales, $195M PRV sale, and $940M liquidity highlight the quarter - TradingViewTradingView · Thu, 06 Aug 2026 20:10:44 GMTDNLI Q2'26 Earnings: EPS estimate is (0.51) USD - TradingViewTradingView · Wed, 05 Aug 2026 11:00:54 GMT

Timeline

Fri, 07 Aug 2026 18:31:00 GMTDNLI Q2 Loss Narrows, Avlayah Sales Drive Strong Launch Momentum - TradingView
Fri, 07 Aug 2026 14:20:14 GMTDenali Therapeutics Inc. Stock 12‑Month Price Target Raised to $35.44, Implies 43% Upside - TradingView
Thu, 06 Aug 2026 23:10:45 GMTDNLI: AVLAYAH's launch drove $3.6M revenue and strong adoption, with Q3 guidance of $10–12M - TradingView
Thu, 06 Aug 2026 21:01:33 GMTDenali Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingView
Thu, 06 Aug 2026 20:13:22 GMTDenali Therapeutics reports $3.6M in Q2 2026 product revenue, pro forma cash >$1.1B - TradingView
Thu, 06 Aug 2026 20:11:01 GMTDenali Therapeutics Inc. 2026: Revenue $3.6M, EPS ($0.68) — 10-Q Summary - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Dnli.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.